Episode Details
Back to Episodes“Sobering” Takeaway From ASCO 2026: Concerns About Clinical Trial Participation
Episode 34
Published 1 month, 3 weeks ago
Description
Amid the exciting advances at ASCO 2026, there came a “sobering moment” regarding the U.S.’s role as a cancer clinical trial leader, says Robert A. Winn, MD. He discusses what this means for cancer centers going forward with Robert A. Figlin, MD.